Menon Jayakumar, Kantipudi Suvarna Jyothi, Vinoth Stanley, Kuchipudi Jyothsna Devi
Department of Psychiatry, SRMC &RI, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Chennai, India.
School of Public Health, University of California, Berkeley, California, USA.
Alzheimers Dement. 2025 Feb;21(2):e14505. doi: 10.1002/alz.14505. Epub 2025 Feb 12.
No studies in India have explored subjective cognitive decline (SCD), a hallmark of stage II of preclinical Alzheimer's disease. This study aims to assess the prevalence and correlates of SCD in a South Indian, urban, elderly population.
We screened 403 individuals 60 years of age and older using the Subjective Memory Complaints Questionnaire (SMCQ) and measured objective cognition with the Montreal Cognitive Assessment (MoCA). Physical health parameters were evaluated for all participants.
Among the participants, 377 (93.5%) reported subjective memory complaints. Of the 26 individuals without SCD, 15(57.7%) had objective cognitive impairment (MoCA <25). A total of 182 participants (45.2%) were identified with SCD. Higher educational attainment was significantly associated with fewer SCD reports and better cognitive performance (p < 0.001).
Subjective cognitive decline (SCD) is highly prevalent among older adults. Screening for SCD can help identify individuals at risk for Alzheimer's disease. SCD assessement combined with cost-effective biomarkers that confirms AD will help individuals to be identified for disease-modifying therapies.
Nearly half of older adults population screened has reported subjective cognitive decline (SCD), highlighting the widespread occurrence of SCD in urban South India. Participants with higher educational attainment had significantly fewer memory complaints and performed better on cognitive assessments. SCD was prevalent even among individuals without major comorbid conditions such as diabetes and hypertension and those who were on regular treatment for metabolic and cardiovascular disorders. Identifying subjective cognitive decline (SCD) can facilitate early and accurate diagnosis of cognitive disorders and help delay progression to dementia. This highlights the importance of developing and implementing improved public health strategies to address these challenges. Further longitudinal studies are necessary to explore the progression of SCD to dementia, focusing on the interplay between cognitive health, biomarkers, and educational factors in the Indian population.
印度尚无研究探索主观认知下降(SCD),这是临床前阿尔茨海默病第二阶段的一个标志。本研究旨在评估南印度城市老年人群中SCD的患病率及其相关因素。
我们使用主观记忆抱怨问卷(SMCQ)对403名60岁及以上的个体进行了筛查,并使用蒙特利尔认知评估量表(MoCA)测量客观认知。对所有参与者的身体健康参数进行了评估。
在参与者中,377人(93.5%)报告有主观记忆抱怨。在26名无SCD的个体中,15人(57.7%)存在客观认知障碍(MoCA<25)。共有182名参与者(45.2%)被确定为有SCD。受教育程度较高与SCD报告较少及认知表现较好显著相关(p<0.001)。
主观认知下降(SCD)在老年人中非常普遍。对SCD进行筛查有助于识别有患阿尔茨海默病风险的个体。将SCD评估与确认阿尔茨海默病的经济有效的生物标志物相结合,将有助于识别适合进行疾病修饰治疗的个体。
在接受筛查的老年人群中,近一半报告有主观认知下降(SCD),这凸显了SCD在南印度城市的广泛存在。受教育程度较高的参与者记忆抱怨明显较少,在认知评估中的表现也更好。即使在没有糖尿病和高血压等主要合并症以及那些接受代谢和心血管疾病常规治疗的个体中,SCD也很普遍。识别主观认知下降(SCD)有助于早期准确诊断认知障碍,并有助于延缓向痴呆症的进展。这凸显了制定和实施改进的公共卫生策略以应对这些挑战的重要性。有必要进行进一步的纵向研究,以探索SCD向痴呆症的进展,重点关注印度人群中认知健康、生物标志物和教育因素之间的相互作用。